News

In addition to a health plan for employees, Johns Hopkins Health Plans has a Medicare Advantage plan, a Medicaid managed care plan and a plan for the families of people who are on active duty in the U.S. military.

In a study recently published in the JAMA Network, researchers sought to investigate the use of patient-facing digital health technologies for opioid use disorder (OUD) by organizations in the United States with ACO contracts. The search began as it was unclear whether these technologies serve as substitute or complements to traditional SUD treatment resources in health care organizations.

Emissions from healthcare facilities contribute to climate change, and climate change, in turn, is presenting new challenges for healthcare.

Bryant Hoyal, VP of Client Services, Strategic Accounts at Relatient suggests filling appointment schedules with patients based on their specific needs through best practices is an efficient way to drive revenue, as well as balance workflows for staff. Outside of scheduling tools, Hoyal stressed the importance of being a data-driven organization to understand and control the workflow of your practice.

Approvals this week include Opill, the first nonprescription oral contraceptive, the use of Veklury for COVID-19 in patients with severe renal impairment, and the earlier use of Leqvio for in heart disease. In addition, Takeda pulled its application for a dengue vaccine.

Bryant Hoyal, VP of Client Services, Strategic Accounts at Relatient explains to Managed Healthcare Executive how providers can address burnout through clinic scheduling.

Whole genomic-sequencing achieved a higher molecular diagnostic yield but had a longer time to return of results than a targeted neonatal gene-sequencing test.

CVS has said it will sell the OTC oral contraceptive, but news reports today said it probably won't be available in the U.S. till early next year.

Many companies are pursuing interchangeable status.

Because personal information can be discovered rather easily through ‘reidentification,’ additional steps are needed to protect the privacy of people’s healthcare data.

Briana Contreras, an editor of Managed Healthcare Executive, spoke with Brian Adams, President and CEO of Tabula Rasa HealthCare, in this month's episode of Tuning In to the C-Suite podcast.

Amgen’s Amjevita was already on the pharmacy benefit manager’s National Preferred Flex Formulary.

Tony Little, ND, VP of Solutions Architecture at Prescryptive Health, shares how the organization is tackling one of the biggest barriers to prescription adherence — cost — through a digital app, among the other barriers patients face.

This week, the FDA granted full approval to the Alzheimer’s drug Leqembi, set an action for review of zolbetuximab to treat gastric cancers and rejected Amneal’s new drug application (NDA) Parkinson’s disease treatment.

In this population-based cohort study, researchers compared the risks of incident cardiovascular, neurological, and mental health conditions and rheumatoid arthritis in a year following COVID hospitalization to three different groups: pre-pandemic hospitalization for influenza, pre-pandemic hospitalization for sepsis and hospitalization for sepsis post-pandemic.

Medicare-eligible patients need to be enrolled in registry to get Medicare coverage for the anti-beta amyloid drug that is priced to cost $26,500 a year.

The Magellan Rx Management CEO is replacing Ken Paulus, who has held the top job at Prime since May 2019.

The Magellan Rx Management CEO is replacing Ken Paulus, who held the top job at Prime since May 2019.

7 of them launched during the first several days of July, joining Amgen's Amjevita in the suddenly crowded market of Humira competitors. Pfizer’s Abrilada is the only FDA-approved Humira biosimilar that hasn’t launched.

Walmart has opened 70 Specialty Pharmacies of the Community locations across the U.S. in June, and is expected to open 80 more in 11 states by the end of the year.

Boehringer Ingelheim is pricing its biosimilar 5% to 7% below AbbVie’s top selling drug.

Approvals this week include: a $2.9 million gene therapy for hemophilia A; a pediatric growth hormone; the first cell therapy for type 1 diabetes; a new alopecia drug; a therapy for generalized myasthenia gravis; and full approval for Blincyto in B-cell ALL. The agency also rejected a higher dose of Eylea and set an action for hemophilia B gene therapy.

Stroke patients treated in home-based and hospital-based rehabilitation had mean scores of QOL assessment improved significantly after intervention. Though, the hospital-based group had better improvement than the home-based group in mobility, self-care, pain/ discomfort and depression/anxiety.

Data revealed that just one minute of downtime costs the average business $5,600.

Removing out-of-pocket expenses for the accessible virtual visits may help improve health equity by reducing medical costs for consumers and encourage earlier interventions. In turn, interventions may reduce the risk of complications and avoid visits to more expensive settings like the emergency room.

Data from a survey conducted by Central Michigan University College of Medicine found that newborn weight can be reduced somewhat by marijuana exposure even if it only occurs early in the pregnancy, while reduced head circumference was caused by exposure continued through the second trimester.